Dupilumab in Adults and Adolescents with Eosinophilic EsophagitisEvan S. Dellon, Arsalan Shabbir, Marc E. Rothenberg et al.|New England Journal of Medicine|2022Cited by 452
Dupilumab for Eosinophilic Esophagitis in Patients 1 to 11 Years of AgeMirna Chehade, Jennifer Maloney, Lila Glotfelty et al.|New England Journal of Medicine|2024Cited by 107
Efficacy and safety of dupilumab up to 52 weeks in adults and adolescents with eosinophilic oesophagitis (LIBERTY EoE TREET study): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trialMarc E. Rothenberg, Arsalan Shabbir, Evan S. Dellon et al.|The Lancet. Gastroenterology & hepatology|2023Cited by 100
Feeding difficulties in children with non–IgE-mediated food allergic gastrointestinal disordersMirna Chehade, Alexia Beauregard, Rosan Meyer|Annals of Allergy Asthma & Immunology|2019Cited by 55
Open-label, add-on trial of cetirizine for neuromyelitis opticaIlana Katz Sand, Fred Lublin, Michelle Fabian et al.|Neurology Neuroimmunology & Neuroinflammation|2018Cited by 26